Maria Luisa Brandi spends much of her time researching Internal medicine, Endocrinology, Osteoporosis, Surgery and Bone mineral. Her Internal medicine research is multidisciplinary, incorporating elements of Multiple endocrine neoplasia and Polymorphism. Her Multiple endocrine neoplasia study also includes
Within one scientific family, she focuses on topics pertaining to Genotype under Endocrinology, and may sometimes address concerns connected to Aromatase. The concepts of her Osteoporosis study are interwoven with issues in Calcitriol receptor and Randomized controlled trial. Her biological study spans a wide range of topics, including Hip fracture, Parathyroidectomy, Strontium ranelate, Placebo and Osteonecrosis of the jaw.
Her main research concerns Internal medicine, Endocrinology, Osteoporosis, Bone remodeling and Pathology. Her Internal medicine research includes themes of Gastroenterology and Multiple endocrine neoplasia. MEN1 is closely connected to Primary hyperparathyroidism in her research, which is encompassed under the umbrella topic of Multiple endocrine neoplasia.
The various areas that Maria Luisa Brandi examines in her Endocrinology study include Receptor, Cell culture, Parathyroid chief cell and Estrogen receptor. Her study in Osteoporosis is interdisciplinary in nature, drawing from both Physical therapy, Surgery and Intensive care medicine. Maria Luisa Brandi usually deals with Parathyroid hormone and limits it to topics linked to Hypoparathyroidism and Pediatrics.
Her primary scientific interests are in Internal medicine, Osteoporosis, Hypoparathyroidism, Pediatrics and MEN1. Maria Luisa Brandi interconnects Gastroenterology and Endocrinology in the investigation of issues within Internal medicine. The study incorporates disciplines such as Receptor, Secondary hyperparathyroidism and Calcium-sensing receptor in addition to Endocrinology.
In her research, Orthopedic surgery and Osteoarthritis is intimately related to Physical therapy, which falls under the overarching field of Osteoporosis. Her Pediatrics research incorporates elements of Epidemiology, Disease and Retrospective cohort study. Her MEN1 study incorporates themes from Neuroendocrine tumors, Epigenetics and Bioinformatics.
Maria Luisa Brandi mostly deals with Osteoporosis, Internal medicine, Disease, Physical therapy and Bone remodeling. Many of her studies involve connections with topics such as Intensive care medicine and Osteoporosis. Her studies in Internal medicine integrate themes in fields like Placebo, Endocrinology and Drug.
Specifically, her work in Endocrinology is concerned with the study of Homeostasis. She has researched Disease in several fields, including Hypoparathyroidism, Pediatrics, MEDLINE and Lactose intolerance. Her Bone remodeling research is multidisciplinary, relying on both Oxidative stress, Food science, Calcium metabolism, Bone density and Bone regeneration.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Maria Luisa Brandi;Robert F. Gagel;Alberto Angeli;John P. Bilezikian.
The Journal of Clinical Endocrinology and Metabolism (2001)
Intravenous zoledronic acid in postmenopausal women with low bone mineral density.
Ian R. Reid;Jacques P. Brown;Peter Burckhardt;Zebulun Horowitz.
The New England Journal of Medicine (2002)
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)
Rajesh V. Thakker;Paul J. Newey;Gerard V. Walls;John Bilezikian.
The Journal of Clinical Endocrinology and Metabolism (2012)
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture
Karol Estrada;Unnur Styrkarsdottir;Evangelos Evangelou;Yi-Hsiang Hsu.
Nature Genetics (2012)
Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
Aliya A Khan;Archie Morrison;David A Hanley;Dieter Felsenberg.
Journal of Bone and Mineral Research (2015)
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes.
Robert T. Jensen;Guillaume Cadiot;Maria L. Brandi;Wouter W. de Herder.
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Kenneth G. Saag;Jeffrey Petersen;Maria Luisa Brandi;Andrew C. Karaplis.
The New England Journal of Medicine (2017)
Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target‐organ involvement, treatment, and challenges for future research
John P Bilezikian;Aliya Khan;John T Potts;Maria Luisa Brandi.
Journal of Bone and Mineral Research (2011)
Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor.
Ettore Luzi;Francesca Marini;Silvia Carbonell Sala;Isabella Tognarini.
Journal of Bone and Mineral Research (2007)
An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Olivier Bruyère;Cyrus Cooper;Cyrus Cooper;Jean-Pierre Pelletier;Jaime Branco.
Seminars in Arthritis and Rheumatism (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: